Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Garrett-Mayer

Showing results (211-220 of 275) with videos related to

Pageof 28
Sort By:
BMC Cancer|December 12, 2018
Deletion of the murine ortholog of the 8q24 gene desert has anti-cancer effects in transgenic mammary cancer modelsCollin Homer-Bouthiette, Yang Zhao, Lauren B Shunkwiler, et al.
Cancer Immunology, Immunotherapy : CII|February 14, 2015
Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cellsMark P Rubinstein, Ee Wern Su, Samantha Suriano, et al.
Journal of Hematology & Oncology|April 9, 2017
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancerShikhar Mehrotra, Carolyn D Britten, Steve Chin, et al.
JCO Oncology Practice|October 25, 2021
Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO RegistryKathryn F Mileham, Suanna S Bruinooge, Charu Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2021
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work GroupAllison Magnuson, Suanna S Bruinooge, Harpreet Singh, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2007
Tamoxifen-stimulated growth of breast cancer due to p21 lossAbde M Abukhdeir, Michele I Vitolo, Pedram Argani, et al.
JCO Precision Oncology|June 12, 2024
Talazoparib in Patients With Solid Tumors With <i>BRCA1</i>/<i>2</i> Mutation: Results From the Targeted Agent and Profiling Utilization Registry StudyGordan Srkalovic, Michael Rothe, Pam K Mangat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2007
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphomaJavier Bolaños-Meade, Elizabeth Garrett-Mayer, Leo Luznik, et al.
Cancer Immunology, Immunotherapy : CII|October 28, 2016
Alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in miceJonathan M Eby, Levi Barse, Steven W Henning, et al.
Clinical Pharmacology and Therapeutics|October 16, 2021
Real-world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research PilotLaura Lasiter, Olga Tymejczyk, Elizabeth Garrett-Mayer, et al.
Pageof 28

Showing results (211-220 of 275) with videos related to

Sort By:
Pageof 28
BMC Cancer|December 12, 2018
Deletion of the murine ortholog of the 8q24 gene desert has anti-cancer effects in transgenic mammary cancer modelsCollin Homer-Bouthiette, Yang Zhao, Lauren B Shunkwiler, et al.
Cancer Immunology, Immunotherapy : CII|February 14, 2015
Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cellsMark P Rubinstein, Ee Wern Su, Samantha Suriano, et al.
Journal of Hematology & Oncology|April 9, 2017
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancerShikhar Mehrotra, Carolyn D Britten, Steve Chin, et al.
JCO Oncology Practice|October 25, 2021
Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO RegistryKathryn F Mileham, Suanna S Bruinooge, Charu Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2021
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work GroupAllison Magnuson, Suanna S Bruinooge, Harpreet Singh, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2007
Tamoxifen-stimulated growth of breast cancer due to p21 lossAbde M Abukhdeir, Michele I Vitolo, Pedram Argani, et al.
JCO Precision Oncology|June 12, 2024
Talazoparib in Patients With Solid Tumors With <i>BRCA1</i>/<i>2</i> Mutation: Results From the Targeted Agent and Profiling Utilization Registry StudyGordan Srkalovic, Michael Rothe, Pam K Mangat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2007
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphomaJavier Bolaños-Meade, Elizabeth Garrett-Mayer, Leo Luznik, et al.
Cancer Immunology, Immunotherapy : CII|October 28, 2016
Alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in miceJonathan M Eby, Levi Barse, Steven W Henning, et al.
Clinical Pharmacology and Therapeutics|October 16, 2021
Real-world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research PilotLaura Lasiter, Olga Tymejczyk, Elizabeth Garrett-Mayer, et al.
Pageof 28